Table 2.

Suggested follow-up of patients treated with plasma-derived C1 inhibitor (C1-INH)

Baseline assessment prior to starting C1-INH	Test	Frequency
	LFTs	Baseline
	HIV serology	Baseline
	HepB-surface ag	Baseline
	HCV-Ab	Baseline
	Give hepatitis	Baseline (series
	B vaccine	of 3 injections)
Twelve-month intervals	LFTs	Every 12 months

Note: Presently no guidelines exist for serial assessment of patients on C1-INH in the US and the table includes information that is expected to be included in future guidelines.

Abbreviation: LFTs, liver function tests.